Propeller Digital Health Platform
Connected inhaler system for asthma and COPD management
Company profile
Company profile
Propeller Health is a digital health company specializing in respiratory disease management solutions for patients with asthma and chronic obstructive pulmonary disease (COPD). The company develops sensor-based technology that attaches to inhalers and nebulizers to automatically track medication usage and provide insights to patients, caregivers, and healthcare providers. Propeller's platform combines hardware sensors with mobile applications and cloud-based analytics to help improve medication adherence, reduce rescue inhaler use, and provide actionable data for clinical decision-making. The company serves health systems, payers, pharmaceutical companies, and individual patients, offering both direct-to-consumer and enterprise solutions. Propeller Health's approach integrates real-world evidence collection with personalized patient engagement tools, aiming to improve outcomes for the millions of people living with chronic respiratory conditions. The platform provides environmental trigger tracking, medication reminders, and educational content while generating valuable data insights for healthcare stakeholders seeking to better manage respiratory disease populations.
Company description Propeller Health official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas deployment with recorded integration context.
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Connected inhaler system for asthma and COPD management
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
ERJ open research · Sep 1, 2025
Impacts of port and locomotive-related air pollution on respiratory symptoms within vulnerable communities in Southern California.Environment international · Aug 1, 2025
Examining air pollution exposure dynamics in disadvantaged communities through high-resolution mapping.Science advances · Aug 9, 2024
Health effects of air pollution on respiratory symptoms: A longitudinal study using digital health sensors.Environment international · Jul 1, 2024
Prediction of short-acting beta-agonist usage in patients with asthma using temporal-convolutional neural networks.JAMIA open · Dec 1, 2023
Reply to "Breath-taking compliance: Does lower adherence translate to inferiority?".The journal of allergy and clinical immunology. In practice · Dec 1, 2023
Clinical validation
No linked records are currently available.
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
respiratory disease management
asthma and COPD patients
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on Propeller Health's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies using AI and digital health tools to help patients manage chronic conditions through digital therapeutics, gamified health management, and AI-powered coaching. Covers management of all chronic diseases including diabetes, hypertension, COPD, heart disease, and multi-condition platforms. Includes continuous glucose monitoring (CGM) systems with AI analytics and insulin optimization algorithms.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.